Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy.

Japanese journal of ophthalmology 20120701

Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.

Japanese journal of ophthalmology 20120701

In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401

Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.

Archives of ophthalmology (Chicago, Ill. : 1960) 20120401

Overview of the [corrected] travoprost /timolol BAK-free fixed combination.

Expert opinion on pharmacotherapy 20120401

Dose response for travoprost® in the glaucomatous beagle.

Veterinary ophthalmology 20120301

Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial.

The British journal of ophthalmology 20120201

The influence of central corneal thickness on response to topical prostaglandin analogue therapy.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20120201

Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.

Journal of glaucoma 20120101

Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.

Journal of glaucoma 20120101

Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120101

Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.

European journal of ophthalmology 20120101

Effect of ketorolac add-on treatment on intra-ocular pressure in glaucoma patients receiving prostaglandin analogues.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20120101

Prostaglandin-timolol fixed combinations efficacy: myth or reality?

European journal of ophthalmology 20120101

Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.

European journal of ophthalmology 20120101

Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma.

European journal of ophthalmology 20120101

Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.

Ophthalmic research 20120101

The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.

Ophthalmic research 20120101

The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells.

Molecular vision 20120101

A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.

TheScientificWorldJournal 20120101

Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model.

PloS one 20120101

Evaluation of investigator bias in industry-funded clinical trials of latanoprost.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Monocular trial of intraocular pressure-lowering medication: a prospective study.

Ophthalmology 20111101

Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs.

Japanese journal of ophthalmology 20111101

Effect of acute increases of intraocular pressure on corneal pachymetry in eyes treated with travoprost: an animal study.

Current eye research 20111101

Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.

Current eye research 20111101

Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.

The British journal of ophthalmology 20111001

Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.

Ophthalmology 20111001

Polyoxyethylene hydrogenated castor oil modulates benzalkonium chloride toxicity: comparison of acute corneal barrier dysfunction induced by travoprost Z and travoprost.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

Do prostaglandin analogs affect eyelid position and motility?

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

A case hypersensitive to bimatoprost and dexamethasone.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension.

Clinical & experimental optometry 20110901

Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost.

Optometry and vision science : official publication of the American Academy of Optometry 20110901

Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy.

Eye (London, England) 20110901

[The influence of the Travalert(®) dosing aid on medical treatment compliance and the quality of life of glaucoma patients].

Archivos de la Sociedad Espanola de Oftalmologia 20110901

Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.

The American journal of managed care 20110901

The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes.

Acta ophthalmologica 20110801

A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma.

Journal of glaucoma 20110801

Macular retinoschisis associated with normal tension glaucoma.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110801

The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.

Cornea 20110801

Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.

Advances in therapy 20110801

Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110701

In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110601

Sturge-Weber syndrome and glaucoma.

Optometry (St. Louis, Mo.) 20110501

Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.

Advances in therapy 20110401

[Effects of travoprost on actin cytoskeleton and β-catenin in the human trabecular meshwork cells treated with Dexamethasone].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20110401

24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110301

Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201

Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.

Expert opinion on pharmacotherapy 20110201

[Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20110201

Do adherence rates and glaucomatous visual field progression correlate?

European journal of ophthalmology 20110101

Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.

Japanese journal of ophthalmology 20110101

Real-life experience study of the safety and efficacy of travoprost 0.004% / timoptol 0.50% fixed combination ophthalmic solution in intraocular pressure control.

Nigerian journal of clinical practice 20110101

Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.

BMC ophthalmology 20110101

[In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110101

Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).

Molecular vision 20110101

A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy.

BMC ophthalmology 20110101

Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases.

BMC ophthalmology 20110101

Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.

Molecular vision 20110101

Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis.

The patient 20110101

[Adjunctive therapy with brinzolamide in patients on travoprost treatment].

Medicinski pregled 20110101

[The latest developments in glaucoma therapy using fixed combination products].

Oftalmologia (Bucharest, Romania : 1990) 20110101

[Fixed combination of topical prostaglandin analogue in glaucoma treatment].

Oftalmologia (Bucharest, Romania : 1990) 20110101

Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost.

Experimental eye research 20101201

Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.

Orbit (Amsterdam, Netherlands) 20101201

Efficacy and safety of topical travoprost with sofzia preservative for Japanese glaucoma patients.

Hiroshima journal of medical sciences 20101201

Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period.

Acta clinica Croatica 20101201

Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.

Advances in therapy 20101101

Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.

Clinical & experimental ophthalmology 20101001

24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.

Eye (London, England) 20101001

Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.

American journal of ophthalmology 20101001

Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in Croatia.

Methods and findings in experimental and clinical pharmacology 20101001

Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).

Journal of glaucoma 20100901

Comparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 month period.

Collegium antropologicum 20100901

Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid.

Eye (London, England) 20100801

Eyelash preservation during chemotherapy and topical prostaglandin therapy.

Archives of internal medicine 20100726

In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601

Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601

Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension.

Chinese medical journal 20100601

Physicians' treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma.

Current medical research and opinion 20100401

Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401

Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401

Eyelash growth: a beneficial side effect of prostaglandin analogues.

Cutis 20100401

Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.

Journal of glaucoma 20100301

Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.

Expert opinion on pharmacotherapy 20100301

Asymptomatic bradycardia possibly associated with travoprost therapy.

Journal of pharmacy practice 20100201

Skin pigmentation after NB-UVB and three analogues of prostaglandin F(2alpha) in guinea pigs: a comparative study.

Journal of the European Academy of Dermatology and Venereology : JEADV 20100101

Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.

The British journal of ophthalmology 20100101

Comparison of corneal wound healing rates after instillation of commercially available latanoprost and travoprost in rat debrided corneal epithelium.

Journal of oleo science 20100101

Effects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprost.

Japanese journal of ophthalmology 20100101

Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy.

BMC ophthalmology 20100101

Goldmann applanation tonometry and dynamic contour tonometry after treatment with prostaglandin analog/prostamide.

Journal of glaucoma 20100101

Hypertrichosis of the upper cheek area associated with travoprost treatment of glaucoma.

Ophthalmic plastic and reconstructive surgery 20100101

[Monotherapy with lipid structural derivatives in glaucoma].

Oftalmologia (Bucharest, Romania : 1990) 20100101

Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomes.

Eye (London, England) 20091201

Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.

Ophthalmology 20091201

Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides.

Expert opinion on pharmacotherapy 20091201

Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201

Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201

Central corneal thickness during treatment with travoprost 0.004% in glaucoma patients.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091001

Comparison of the protective effects of prostaglandin analogues in the ischemia and reperfusion model of rabbit eyes.

Experimental animals 20091001

Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.

Ophthalmology 20090901

Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.

American journal of ophthalmology 20090801

Comment on Efficacy and tolerability of prostaglandin analogs.

Journal of glaucoma 20090801

Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.

Expert opinion on pharmacotherapy 20090801

Meta-analysis of medical intervention for normal tension glaucoma.

Ophthalmology 20090701

Corneal thickness and glaucoma medications.

Ophthalmology 20090701

Relative efficacy of prostaglandins.

Ophthalmology 20090701

Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.

Ophthalmology 20090601

Changes in visual function after intraocular pressure reduction using antiglaucoma medications.

Eye (London, England) 20090501

Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.

The British journal of ophthalmology 20090401

First-year treatment patterns among new initiators of topical prostaglandin analogs.

Current medical research and opinion 20090401

The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401

Intraocular pressure control among patients transitioned from latanoprost to travoprost at a Veterans Affairs Medical Center Eye Clinic.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401

[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].

Archivos de la Sociedad Espanola de Oftalmologia 20090401

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

The British journal of ophthalmology 20090301

Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment.

Journal of glaucoma 20090301

Deepening of eyelid superior sulcus during topical travoprost treatment.

Japanese journal of ophthalmology 20090301

The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy.

Acta clinica Croatica 20090301

Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.

Ophthalmology 20090201

Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.

Acta ophthalmologica 20090201

Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004%.

Journal of glaucoma 20090201

Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201

The effect of prostaglandin analogs and prostamide on central corneal thickness.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201

Travoprost in children: adverse effects and intraocular pressure response.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20090201

Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.

American journal of ophthalmology 20090101

Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.

Clinical drug investigation 20090101

Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.

Japanese journal of ophthalmology 20090101

Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study.

Current medical research and opinion 20090101

[Efficacy of latanoprost versus travoprost assessed by daily intraocular pressure curve].

Arquivos brasileiros de oftalmologia 20090101

Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma.

Journal of glaucoma 20090101

Efficiency of travoprost versus fixed-combination latanoprost/timolol.

Clinical drug investigation 20090101

Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.

BMC ophthalmology 20090101

[Receptors involved in the mechanism of action of topical prostaglandines].

Oftalmologia (Bucharest, Romania : 1990) 20090101

Evaluation of monkey intraocular pressure by rebound tonometer.

Molecular vision 20090101

[Bimatoprost therapy in glaucoma].

Oftalmologia (Bucharest, Romania : 1990) 20090101

Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report.

Puerto Rico health sciences journal 20081201

Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

Journal of glaucoma 20081201

Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma .

Current medical research and opinion 20081101

Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues.

Investigative ophthalmology & visual science 20081101

Prostanoids for the management of glaucoma.

Expert opinion on drug safety 20081101

Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Survey of ophthalmology 20081101

Uveal effusion induced by topical travoprost in a patient with Sturge-Weber-Krabbe syndrome.

Journal francais d'ophtalmologie 20081101

Local effect of topical FP-receptor agonists on retinal vessels of the ipsilateral posterior retina in normal rabbit eyes.

Clinical & experimental ophthalmology 20081101

A case of melancholic depression induced by beta-blocker antiglaucoma agents.

The Medical journal of Australia 20081006

[Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].

Archivos de la Sociedad Espanola de Oftalmologia 20081001

Additive effect of dorzolamide hydrochloride to patients taking travoprost: a retrospective study.

Optometry (St. Louis, Mo.) 20080901

The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trial.

The British journal of ophthalmology 20080801

Observational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in Germany.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801

Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.

Advances in therapy 20080801

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Ophthalmology 20080701

[Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20080701

Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.

Current medical research and opinion 20080601

Hypotony and choroidal detachment as a complication of travoprost after trabeculectomy surgery.

Eye (London, England) 20080501

Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.

Ophthalmology 20080501

Gastrointestinal adverse effects of prostaglandin analogues.

Archives of ophthalmology (Chicago, Ill. : 1960) 20080501

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.

Current medical research and opinion 20080401

A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.

Current medical research and opinion 20080401

Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.

Cornea 20080401

Travoprost/timolol fixed combination.

Expert opinion on pharmacotherapy 20080401

In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.

Current eye research 20080401

Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro.

Prostaglandins, leukotrienes, and essential fatty acids 20080301

The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.

Eye (London, England) 20080201

Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.

American journal of ophthalmology 20080201

Accuracy of the ICare rebound tonometer in glaucomatous eyes with topical ocular hypotensive medication.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) 20080101

Treatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation model.

European journal of ophthalmology 20080101

Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.

Clinical drug investigation 20080101

A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20080101

The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.

Journal of glaucoma 20080101

Physician attitudes regarding prostaglandin treatment for glaucoma in the United States and Europe.

European journal of ophthalmology 20080101

Duration of IOP reduction with travoprost BAK-free solution.

Journal of glaucoma 20080101

Comparison of ocular surface side effects of topical travoprost and bimatoprost.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20080101

[Periocular hyperpigmentation following travoprost application].

Annales de dermatologie et de venereologie 20080101

Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study.

Clinical drug investigation 20080101

[Considerations about administration angle of prostaglandin analogs].

Arquivos brasileiros de oftalmologia 20080101

[Glaucoma--strategy of treatment].

Oftalmologia (Bucharest, Romania : 1990) 20080101

[Fixed combinations of glaucoma medications].

Oftalmologia (Bucharest, Romania : 1990) 20080101

[Ocular surface disfunction in glaucoma].

Oftalmologia (Bucharest, Romania : 1990) 20080101

Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

Acta ophthalmologica Scandinavica 20071201

Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.

Current medical research and opinion 20071201

Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201

A gap analysis approach to assess patient persistence with glaucoma medication.

American journal of ophthalmology 20071001

In vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chloride.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001

Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001

Corneal oedema and acute anterior uveitis after two doses of travoprost.

Acta ophthalmologica Scandinavica 20070901

Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.

Ophthalmology 20070901

In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.

Investigative ophthalmology & visual science 20070901

Effects of topical travoprost and unoprostone on optic nerve head circulation in normal rabbits.

Current eye research 20070901

A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

Clinical therapeutics 20070901

Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle.

Investigative ophthalmology & visual science 20070801

Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.

Clinical therapeutics 20070801

Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.

Ophthalmology 20070701

Ocular therapeutics.

Clinical & experimental optometry 20070701

24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.

Eye (London, England) 20070401

Accuracy and performance of a commercially available Dosing Aid.

The British journal of ophthalmology 20070401

Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients.

Ophthalmology 20070401

The TRAVATAN Dosing Aid accurately records when drops are taken.

American journal of ophthalmology 20070401

Accounting for restart rates in evaluating persistence with ocular hypotensives.

Ophthalmology 20070401

Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes.

Journal of the European Academy of Dermatology and Venereology : JEADV 20070301

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Current medical research and opinion 20070301

Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.

Journal of glaucoma 20070301

Conjunctival hyperaemia and other ocular adverse effects on healthy African subjects after single dosing with 0.004% Travoprost.

African journal of medicine and medical sciences 20070301

Travoprost 0.004%/timolol 0.5% fixed combination.

Drugs of today (Barcelona, Spain : 1998) 20070201

Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.

Cornea 20070101

Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy.

Journal of glaucoma 20070101

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

European journal of ophthalmology 20070101

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.

BMC ophthalmology 20070101

Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.

Oftalmologia (Bucharest, Romania : 1990) 20070101

Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.

Clinical drug investigation 20070101

The effect of ocular hypotensive agents on macula.

Annals of ophthalmology (Skokie, Ill.) 20070101

Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma.

Journal of glaucoma 20070101

Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study.

Arquivos brasileiros de oftalmologia 20070101

[Prostaglandin analogues and central corneal thickness].

Oftalmologia (Bucharest, Romania : 1990) 20070101

Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061201

Efficiency of instillation methods for prostaglandin medications.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061201

Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

The British journal of ophthalmology 20061101

Clinical course of bimatoprost-induced periocular skin changes in Caucasians.

Ophthalmology 20061101

Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

The British journal of ophthalmology 20061101

Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

Clinical & experimental ophthalmology 20061101

Comparing bimatoprost and travoprost in black Americans.

Current medical research and opinion 20061101

Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.

Clinical therapeutics 20061101

Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension.

Current medical research and opinion 20060901

Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.

Current medical research and opinion 20060901

Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression.

Current medical research and opinion 20060901

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension.

Current medical research and opinion 20060901

Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.

American journal of ophthalmology 20060801

[The Slovak study of the travoprost treatment efficacy].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20060701

Does timolol LA enhance the disrupting effect of travoprost on the blood-aqueous barrier?

Acta ophthalmologica Scandinavica 20060601

Sustained effect of travoprost on diurnal and nocturnal intraocular pressure.

American journal of ophthalmology 20060601

Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.

Current medical research and opinion 20060501

Bilateral anterior uveitis associated with travoprost.

Acta ophthalmologica Scandinavica 20060401

A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.

Clinical therapeutics 20060401

Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.

Investigative ophthalmology & visual science 20060301

24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma.

Ophthalmology 20060301

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Clinical therapeutics 20060301

Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops.

Journal of glaucoma 20060201

Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

Ophthalmology 20060201

The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20060201

Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries.

Investigative ophthalmology & visual science 20060101

Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.

American journal of ophthalmology 20060101

A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.

European journal of ophthalmology 20060101

Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs.

Veterinary ophthalmology 20060101

A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.

European journal of ophthalmology 20060101

[Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20060101

Travoprost/timolol.

Drugs & aging 20060101

Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.

Advances in therapy 20060101

Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride.

Advances in therapy 20060101

The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma.

European journal of ophthalmology 20060101

Comparison of diurnal intraocular pressure control by latanoprost versus travoprost : results of an observational survey.

Clinical drug investigation 20060101

[Matrix-metalloproteinases and glaucoma].

Oftalmologia (Bucharest, Romania : 1990) 20060101

[Topical prostaglandins influence over cornea--preliminary report].

Klinika oczna 20060101

In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.

Investigative ophthalmology & visual science 20051201

Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication.

Current medical research and opinion 20051201

The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.

Investigative ophthalmology & visual science 20051101

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.

Current medical research and opinion 20051101

A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.

Journal of glaucoma 20051001

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

American journal of ophthalmology 20050801

Choroidal detachment after topical prostaglandin analogs: case report.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050801

In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.

Investigative ophthalmology & visual science 20050701

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.

American journal of ophthalmology 20050701

Modern alchemy: fixed combinations of glaucoma drugs.

American journal of ophthalmology 20050701

Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.

Investigative ophthalmology & visual science 20050601

Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops.

American journal of ophthalmology 20050401

Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.

Eye (London, England) 20050301

Effects of travoprost on aqueous humor dynamics in monkeys.

Journal of glaucoma 20050201

Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.

Archives of ophthalmology (Chicago, Ill. : 1960) 20050201

Abdominal cramp as an adverse effect of travoprost.

American journal of ophthalmology 20050101

[The more favourable cost/effectiveness ratio of latanoprost vs bimatoprost and travoprost when using normally for treatment of glaucoma].

Archivos de la Sociedad Espanola de Oftalmologia 20050101

Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.

Oftalmologia (Bucharest, Romania : 1990) 20050101

[Axial length of the ocular globe and hypotensive effect in glaucoma therapy with prostaglandin analogs].

Oftalmologia (Bucharest, Romania : 1990) 20050101

Stopping prostaglandin analogues in uneventful cataract surgery.

Journal of cataract and refractive surgery 20041201

Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.

Clinical therapeutics 20041201

[Circadian rhythm variations of intraocular pressure and therapeutic decisions: interpretation of clinical trial results based on a statistical model].

Journal francais d'ophtalmologie 20040901

Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.

Archives of ophthalmology (Chicago, Ill. : 1960) 20040901

Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.

Current medical research and opinion 20040901

Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost.

Current medical research and opinion 20040901

[Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].

Klinische Monatsblatter fur Augenheilkunde 20040901

The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20040801

Anterior uveitis is associated with travoprost.

BMJ (Clinical research ed.) 20040724

Trichiasis associated with prostaglandin analog use.

Ophthalmic plastic and reconstructive surgery 20040701

[Cystoid macular edema induced by travoprost].

Archivos de la Sociedad Espanola de Oftalmologia 20040601

Topical prostaglandin F(2alpha) analog induced poliosis.

American journal of ophthalmology 20040501

[Recent changes in glaucoma management].

Nippon Ganka Gakkai zasshi 20040401

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

Survey of ophthalmology 20040301

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.

American journal of ophthalmology 20040201

Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

American journal of ophthalmology 20040101

Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle.

Veterinary ophthalmology 20040101

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

Clinical therapeutics 20040101

[Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].

Oftalmologia (Bucharest, Romania : 1990) 20040101

Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20040101

Intraocular pressure lowering efficacy of travoprost.

European journal of ophthalmology 20040101

[Theoretical and clinical aspects of the use of prostaglandins in glaucoma therapy].

Klinika oczna 20040101

Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects.

Journal of glaucoma 20031201

Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031201

The prostaglandin wars.

American journal of ophthalmology 20031001

Acute anterior uveitis and corneal edema associated with travoprost.

Archives of ophthalmology (Chicago, Ill. : 1960) 20030701

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

American journal of ophthalmology 20030501

Update on prostaglandin analogs.

Current opinion in ophthalmology 20030401

Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.

Clinical therapeutics 20030401

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.

American journal of ophthalmology 20030301

Precautions in use and handling of travoprost.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030301

Absence of vasoactive properties of travoprost in isolated porcine ciliary arteries.

Klinische Monatsblatter fur Augenheilkunde 20030301

Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.

Investigative ophthalmology & visual science 20030201

New topical drugs for open-angle glaucoma.

Drug and therapeutics bulletin 20030201

Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030201

Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.

The Journal of pharmacology and experimental therapeutics 20030101

Bimatoprost (Lumigan((R))) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca(2+) mobilization studies.

Prostaglandins, leukotrienes, and essential fatty acids 20030101

Travoprost: a potent ocular hypotensive agent.

Drugs of today (Barcelona, Spain : 1998) 20030101

Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension.

Advances in therapy 20030101

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension.

Advances in therapy 20030101

[Travatan--preliminary results].

Oftalmologia (Bucharest, Romania : 1990) 20030101

Reappraising first-line treatment in glaucoma management.

Hospital medicine (London, England : 1998) 20020901

Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.

Survey of ophthalmology 20020801

Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

Survey of ophthalmology 20020801

Medical treatment of normal tension glaucoma.

Survey of ophthalmology 20020801

Mechanism and clinical significance of prostaglandin-induced iris pigmentation.

Survey of ophthalmology 20020801

Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020801

Travoprost--a new prostaglandin analogue for the treatment of glaucoma.

Expert opinion on pharmacotherapy 20020701

Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001;10:414-22.

Journal of glaucoma 20020601

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

Ophthalmology 20020501

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

American journal of ophthalmology 20020501

Determination of travoprost and travoprost free acid in human plasma by electrospray HPLC/MS/MS.

Journal of pharmaceutical and biomedical analysis 20020415

Cystoid macular edema associated with ocular hypotensive lipids.

American journal of ophthalmology 20020301

Prostaglandin analog treatment of glaucoma and ocular hypertension.

The Annals of pharmacotherapy 20020301

Drug and device approval highlights from 2001.

The Nurse practitioner 20020201

Pharmacological considerations in the treatment of glaucoma.

Managed care (Langhorne, Pa.) 20020101

Travoprost.

Drugs & aging 20020101

New drugs 2002, part 1.

Nursing 20020101

Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.

Transactions of the American Ophthalmological Society 20020101

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

American journal of ophthalmology 20011201

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

American journal of ophthalmology 20011001

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.

Journal of glaucoma 20011001

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20011001

Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients.

European journal of cancer (Oxford, England : 1990) 19961201